Global Life Science Instruments & Reagents Key Trends and Opportunities to 2027

Life science is changing rapidly and constantly. New discoveries lead to more efficient and faster development of innovative molecular research methods as well as small and large molecular therapeutics – thus creating a basis for sustainable growth in these markets.

On the basis of product

type, Type of Instruments represent the largest share of the worldwide Life Science Instruments & Reagents market, with 52% share. In the applications, Clinical segment is estimated to be the largest end-use industry segment of the market in 2020, with 57% share of global market. North America holds the major share in the market, with a share of 36%.

Market Analysis and Insights: Global Life Science Instruments & Reagents Market
In 2020, the global Life Science Instruments & Reagents market size was US$ 67410 million and it is expected to reach US$ 100870 million by the end of 2027, with a CAGR of 5.9% during 2021-2027.

Global Life Science Instruments & Reagents Scope and Market Size
Life Science Instruments & Reagents market is segmented by companies, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Life Science Instruments & Reagents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on market size and forecast for the period 2016-2027.
Segment by Type, the Life Science Instruments & Reagents market is segmented into Instruments, Reagents, etc.
Segment by Application, the Life Science Instruments & Reagents market is segmented into Commercial & Academic, Clinic, Research Center, etc.

Regional and Country-level Analysis
The report offers exhaustive assessment of different region-wise and country-wise Life Science Instruments & Reagents markets such as the U.S., Canada, Germany, France, the U.K., Italy, Russia, China, Japan, South Korea, Taiwan, India, Australia, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Argentina, Saudi Arabia, UAE, Turkey, etc.
The report includes country-wise and region-wise market size for the period 2016-2027, by countries (regions), by Type, and by Application, as well as by players for North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Competitive Landscape

and Life Science Instruments & Reagents Market Share Analysis
Life Science Instruments & Reagents market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2016-2021. Details included are company description, major business, company total revenue and revenue generated in Life Science Instruments & Reagents business, the date to enter into the Life Science Instruments & Reagents market, Life Science Instruments & Reagents product introduction, recent developments, etc.
The major vendors include Thermo Fisher Scientific, Merck, Danaher, GE Healthcare, BD, Roche, Agilent Technologies, BioMerieux, Bio-Rad Laboratories, PerkinElmer, Waters, Bruker, Shimadzu, Abcam, etc.

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Details
QYR-18433936

03-Jun-2021

187
License